Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-23

FDA Approved: EPTIFIBATIDE — Original Application (Baxter Healthcare Company)

View source ↗

Summary

FDA approval of Baxter Healthcare's original ANDA for eptifibatide (EPTIFIBATIDE), a generic injectable antiplatelet agent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPTIFIBATIDE (EPTIFIBATIDE)

Snippet

ORIG AP for EPTIFIBATIDE (EPTIFIBATIDE)